首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >DESIGN AND CHARACTERIZATION OF SOLID DISPERSED FEXOFENADINE HYDROCHLORIDE BUCCAL FILM BY CENTRAL COMPOSITE DESIGN
【24h】

DESIGN AND CHARACTERIZATION OF SOLID DISPERSED FEXOFENADINE HYDROCHLORIDE BUCCAL FILM BY CENTRAL COMPOSITE DESIGN

机译:中心复合设计法设计和表征固体分散型非索非那定盐酸盐口腔膜

获取原文
获取外文期刊封面目录资料

摘要

Fexofenadine Hydrochloride (FHCl) is a second generation antihistaminic drug which is used in the treatment of allergic rhinitis and urticaria. It is a BCS class II drug and has high first pass metabolism leading to low oral bioavailability. Drug-inclusion complex with 2HPβCD was prepared by kneading method and characterized for solubility study, FTIR study and in vitro dissolution study. Nine different combinations of polymers to be added were generated by Central Composite Design was used to evaluate dependent parameters by varying the independent variables, HPMC E5 and HPMC K4M and responses were tensile strength, mucoadhesive strength and in vitro diffusion. Films were prepared and evaluated for different parameters and found to be in acceptable limits. Optimized formulation F10 generated from the design showed good tensile strength and mucoadhesive strength and optimum in vitro diffusion results. Drug permeation through porcine oral mucosa at the end of 120 mins was 85.59%. Short term stability studies revealed that formulation was stable after storage for 1 month.
机译:盐酸非索非那定(FHCl)是第二代抗组胺药,用于治疗变应性鼻炎和荨麻疹。它是BCS II类药物,具有较高的首过代谢,导致口服生物利用度低。采用捏合法制备了具有2HPβCD的药物包合物,并进行了溶解度研究,FTIR研究和体外溶出研究。 Central Composite Design生成了9种不同的待添加聚合物组合,用于通过改变自变量HPMC E5和HPMC K4M评估相关参数,响应包括拉伸强度,粘膜粘附强度和体外扩散。制备膜并评估不同参数,发现其处于可接受的范围内。通过设计生成的优化配方F10具有良好的拉伸强度和粘膜粘附强度,并具有最佳的体外扩散结果。在120分钟结束时通过猪口腔粘膜的药物渗透率为85.59%。短期稳定性研究表明,制剂储存1个月后稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号